Recruiting studies: Hypercholesterolemia Familial

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Screening for Familial Hypercholesterolemia in Children
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT06555120 2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)
Phase 2 · 1 location(s) · Vanderbilt University Medical Center · NCT04941599 Comparing Direct vs Indirect Methods for Cascade Screening
NA · 1 location(s) · University of Maryland, Baltimore · NCT05348564 A Dose-exploration Study of EDP167 in HoFH
Phase 2 · 1 location(s) · Eddingpharm (Zhuhai) Co., Ltd. · NCT07489209 IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
Phase 3 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07473960 Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Cor
Phase N/A · 13 location(s) · Fondazione SISA (Societa Italiana per lo Studio della Arteri · NCT07447648 PMMHRI - Familial Hypercholesterolemia Registry
Phase N/A · 1 location(s) · Polish Mother Memorial Hospital Research Institute · NCT06571630 Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis
NA · 1 location(s) · Abu Dhabi Health Services Company · NCT06535542 The Spanish Familial Hypercholesterolaemia Cohort Study
Phase N/A · 1 location(s) · Fundación Hipercolesterolemia Familiar · NCT02693548 Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION
Phase 3 · 52 location(s) · Novartis Pharmaceuticals · NCT05682378 Clinical Decision Support for Familial Hypercholesterolemia
NA · 1 location(s) · University Hospital, Linkoeping · NCT03989167 Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.
NA · 2 location(s) · Odense University Hospital · NCT05614219 PET Imaging of Inflammation and Lipid Lowering Study
NA · 1 location(s) · University of Cambridge · NCT04073797 A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07543731 Lipid Transport Disorder Italian Genetic Record (LIPIGEN)
Phase N/A · 1 location(s) · Fondazione SISA (Societa Italiana per lo Studio della Arteri · NCT06362473 Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipide
Phase 3 · 1 location(s) · A. Menarini International Licensing S.A. · NCT07614958 Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozyg
Phase N/A · 3 location(s) · Nantes University Hospital · NCT06634160 Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterole
Phase 3 · 19 location(s) · Novartis Pharmaceuticals · NCT06597006 The ORIGIN-FH Study
NA · 1 location(s) · University of Wisconsin, Madison · NCT07470723 Atlantic Lipid Lowering Treatment Optimization Program
NA · 2 location(s) · Atlantic Health System · NCT06439654 Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)
NA · 9 location(s) · Nantes University Hospital · NCT06960902 Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
Phase 1 · 16 location(s) · Verve Therapeutics, Inc. · NCT06451770 A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familia
Phase 2/Phase 3 · 36 location(s) · Merck Sharp & Dohme LLC · NCT07058077 Russian Familial Hypercholesterolemia Registry
Phase N/A · 5 location(s) · Russian Cardiology Research and Production Center · NCT02208869 Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)
EARLY_Phase 1 · 1 location(s) · RenJi Hospital · NCT06458010 "Detection and Follow-up of Coronary Lesions in HeFH (DESTINY-FH Study)"
NA · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07427472 Cardiovascular Risk in Children With Chronic Conditions Study
Phase N/A · 3 location(s) · Semmelweis University · NCT07086989 NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
EARLY_Phase 1 · 1 location(s) · First Affiliated Hospital Xi'an Jiaotong University · NCT06125847 Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Phase 3 · 66 location(s) · Novartis Pharmaceuticals · NCT06597019 Child-Parent Familial Hypercholesterolemia Screening
Phase N/A · 6 location(s) · Children's Hospital of Fudan University · NCT04529967

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.